American Peptide Company Launches new Website
News Oct 03, 2008
American Peptide Company, Inc. has announced the launch of its newly redesigned corporate website – www.americanpeptide.com.
The website contains extensive information on the company’s new Total Peptide Management program, as well as its broad portfolio of peptides, value-added services, and customer support initiatives.
As a comprehensive resource of American Peptide Company’s capabilities and expertise, the site is designed to meet the needs of pharmaceutical and life sciences companies looking to bring new drugs to market.
The redesigned site incorporates new visual elements, including photography, graphics and colors, as well as improved site architecture, allowing for user-friendly navigation. In addition, the site features ‘My Peptides,’ a tool created to help current customers track their recent orders, change account or order information.
American Peptide Company history, company press releases, trade show schedules, and career opportunities can be explored on the new website. For more information on the company’s products and services visitors may utilize a simple inquiry function, which is provided to help direct the queries correctly.
“We have enhanced our website to better showcase our products, services, and capabilities that enable our customers and prospects to meet their drug research, development, and manufacturing requirements,” explains Takahiro Ogata, president and COO of American Peptide Company.
“In addition, the website also provides pertinent information on our new Total Peptide Management program that is instituted to support the scientific community’s efforts to pioneer innovative drug solutions for preserving and improving human life.”
University of Wisconsin–Madison Professor of Chemistry Shannon Stahl has received the Steenbock Professorship in Chemical Sciences. In addition to advancing the fundamental science in this area, Stahl has been involved in numerous industrial collaborations that have led to practical applications, including target applications relevant to pharmaceutical synthesis.READ MORE